Talzenna bags EU approval for gBRCA-mutated breast cancer

24th June 2019 Uncategorised 0

The indication is for patients with inherited BRCA-mutated locally advanced or metatastatic breast cancer.

More: Talzenna bags EU approval for gBRCA-mutated breast cancer
Source: News